GeoVax Next-Generation COVID-19 Vaccine Data Presented at Keystone Symposia Conference
20.09.2023 - Preclinical Data for GEO-CM02 Demonstrates Single-Dose ProtectionAgainst Multiple SARS-CoV-2 Variants ATLANTA, GA, Sept. 20, 2023 (GLOBE NEWSWIRE) - via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing ... Seite 1